Read More Pharma Industry News Takeda announces positive results for mezagitamab in Phase 2 ITP study Takeda Pharmaceutical Company Limited has disclosed favorable top-line outcomes from a Phase 2, randomized, double-blind, placebo-controlled trial, assessing… byPallavi MadhirajuMarch 14, 2024